Parkman Healthcare Partners’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.49M | Buy |
647,331
+221,924
| +52% | +$2.91M | 0.98% | 35 |
|
|
2025
Q1 | $9.36M | Buy |
425,407
+44,234
| +12% | +$973K | 1.11% | 34 |
|
|
2024
Q4 | $10.2M | Sell |
381,173
-275,897
| -42% | -$7.37M | 1.36% | 28 |
|
|
2024
Q3 | $17.5M | Buy |
657,070
+82,553
| +14% | +$2.2M | 2.24% | 12 |
|
|
2024
Q2 | $10.3M | Sell |
574,517
-79,136
| -12% | -$1.43M | 1.39% | 25 |
|
|
2024
Q1 | $11.9M | Buy |
653,653
+2,028
| +0.3% | +$37K | 1.46% | 23 |
|
|
2023
Q4 | $7.13M | Buy |
651,625
+178,313
| +38% | +$1.95M | 1% | 33 |
|
|
2023
Q3 | $2.71M | Buy |
473,312
+19,065
| +4% | +$109K | 0.5% | 60 |
|
|
2023
Q2 | $3.52M | Buy |
454,247
+391,964
| +629% | +$3.04M | 0.61% | 53 |
|
|
2023
Q1 | $415K | Buy |
62,283
+9,387
| +18% | +$62.6K | 0.09% | 81 |
|
|
2022
Q4 | $473K | Buy |
52,896
+2,896
| +6% | +$25.9K | 0.13% | 78 |
|
|
2022
Q3 | $492K | Buy |
+50,000
| New | +$492K | 0.14% | 84 |
|